Published in
Elsevier, European Journal of Cancer, (142), p. 132-140, 2021
DOI: 10.1016/j.ejca.2020.08.019
Links
Tools
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
Journal article published in 2020 by
Mark Clemons 
,
Michael Ong,
Carol Stober,
Scott Ernst,
Christopher Booth,
Christina Canil,
Mihaela Mates,
Andrew Robinson,
Phillip Blanchette,
Anil Abraham Joy,
John Hilton,
Olexiy Aseyev,
Gregory Pond,
Ahwon Jeong,
Brian Hutton
and other authors.
,
Michael Ong,
Carol Stober,
Scott Ernst,
Christopher Booth,
Christina Canil,
Mihaela Mates,
Andrew Robinson,
Phillip Blanchette,
Anil Abraham Joy,
John Hilton,
Olexiy Aseyev,
Gregory Pond,
Ahwon Jeong,
Brian Hutton
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 